MARATTO

article · International Journal of Community Medicine and Public Health

Perceptions of post vaccination Bacillus Calmette-Guérin scar formation among caregivers in tertiary health institution in North-East, Nigeria

Abstract

Background: Tuberculosis continues to be one of the major causes of morbidity and a leading cause of mortality worldwide, especially in low- and middle-income countries like Nigeria. To effectively contribute to the fight against tuberculosis (TB), mothers must be well-informed about TB and how to prevent TB in children. The objective of this study was to evaluate the knowledge and perception of mothers about Bacillus Calmette-Guérin (BCG) scarring. Methods: This was a cross-sectional descriptive study performed from July to December 2024 in a tertiary health care facility in Yola, Nigeria. Results: Majority (80%) of the caregivers were aware that BCG protects against tuberculosis, about 95% believed BCG can result in scar formation and 61% agree that presence of scar indicates that BCG vaccine is working. About 90% of the caregivers would report to a health facility when the scar fails to appear after BCG vaccination. Conclusions: Majority of the caregivers (mothers) were found to be aware that BCG protects against TB and accept BCG scarring following vaccination. We recommend regular health education to mothers during routine immunization to maintain adequate and accurate health information on vaccines.

Research topics

  • Tuberculosis Research and Epidemiology
  • Immune responses and vaccinations
  • Vaccine Coverage and Hesitancy

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.18203/2394-6040.ijcmph20252454

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.